Authors
WMM Schüpbach, D Maltête, JL Houeto, S Tezenas du Montcel, L Mallet, ML Welter, M Gargiulo, C Béhar, AM Bonnet, V Czernecki, B Pidoux, S Navarro, D Dormont, P Cornu, Y Agid
Publication date
2007/1/23
Journal
Neurology
Volume
68
Issue
4
Pages
267-271
Publisher
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Description
Background: Stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson disease (PD) and is currently performed after a mean disease duration of 14 years, when severe motor complications have resulted in marked loss of quality of life. We examined whether surgery at an early stage would maintain quality of life as well as improve motor function.
Methods: Twenty patients with PD of short duration (time elapsed since first symptom ± SD: 6.8 ± 1.0 years) with mild to moderate motor signs (Unified Parkinson's Disease Rating Scale III “off” medication: 29 ± 12) who responded well to levodopa treatment were included in pairs, matched for age, duration and severity of disease, and impairment in socioprofessional functioning. Patients were prospectively randomized to undergo bilateral subthalamic nucleus stimulation (n = 10) or receive optimized medical treatment (n = 10 …
Total citations
2006200720082009201020112012201320142015201620172018201920202021202220232024111203124222328211815132012671083
Scholar articles